Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
作者信息
Kaur Kirandeep, Gurnani Bharat
机构信息
Consultant Cataract, Pediatric Ophthalmology and Strabismus Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Puducherry, India.
Consultant Cataract, Cornea and Refractive Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Puducherry, India.
出版信息
Indian J Pharmacol. 2021 Sep-Oct;53(5):417-419. doi: 10.4103/ijp.ijp_392_21.
Abstract
摘要
相似文献
1
Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
Indian J Pharmacol. 2021 Sep-Oct;53(5):417-419. doi: 10.4103/ijp.ijp_392_21.
2
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Indian J Pharmacol. 2021 Jul-Aug;53(4):317-327. doi: 10.4103/ijp.ijp_419_21.
3
Bilateral Rhino-Orbital-Cerebral Mucormycosis.
JAMA Ophthalmol. 2024 Jul 1;142(7):e236486. doi: 10.1001/jamaophthalmol.2023.6486. Epub 2024 Jul 18.
4
COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
Indian J Pharmacol. 2021 Sep-Oct;53(5):415-416. doi: 10.4103/ijp.ijp_406_21.
5
Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.
Mycoses. 2016 Dec;59(12):765-772. doi: 10.1111/myc.12529. Epub 2016 Jul 22.
6
Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy.
Scand J Infect Dis. 2004;36(9):643-8. doi: 10.1080/00365540410020794.
7
Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis.
JAMA Ophthalmol. 2022 May 1;140(5):548. doi: 10.1001/jamaophthalmol.2022.0618.
8
COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Indian J Pharmacol. 2021 Nov-Dec;53(6):499-510. doi: 10.4103/ijp.ijp_839_21.
9
Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.
JAMA Ophthalmol. 2022 May 1;140(5):548-549. doi: 10.1001/jamaophthalmol.2022.0617.
10
Rhino-orbital-cerebral Mucormycosis.
N Engl J Med. 2024 Mar 21;390(12):e30. doi: 10.1056/NEJMicm2309352. Epub 2024 Mar 16.
引用本文的文献
1
Risk Factors for COVID-19 Associated Mucormycosis: The Ophthalmologist's Perspective.
J Fungi (Basel). 2022 Mar 8;8(3):271. doi: 10.3390/jof8030271.
本文引用的文献
1
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
Int J Antimicrob Agents. 2020 Aug;56(2):106054. doi: 10.1016/j.ijantimicag.2020.106054. Epub 2020 Jun 10.
2
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
3
Therapy of Mucormycosis.
J Fungi (Basel). 2018 Jul 31;4(3):90. doi: 10.3390/jof4030090.
4
Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
Ophthalmic Plast Reconstr Surg. 2017 Jul/Aug;33(4):e94-e97. doi: 10.1097/IOP.0000000000000806.
5
Intraorbital Irrigation of Amphotericin B in the Treatment of Rhino-Orbital Mucormycosis.
Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;33(1):e13-e16. doi: 10.1097/IOP.0000000000000377.
Zotero 插件